Airsculpt Technologies is trading at $2.33, down 13.85%, after no fresh company-specific catalyst was identified for September 9, 2026.

  • Recent coverage centers on the August 10 revenue miss and reduced EBITDA outlook, not a new announcement.
  • Healthcare is down 2.52% pre-market, providing sector pressure, but not enough evidence to explain the full decline.
  • The move remains unexplained and warrants re-checking for delayed filings or overnight news.